SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUARDIGLI, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.775
AS - Asia 2.372
EU - Europa 1.148
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 74
OC - Oceania 11
Totale 7.891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.646
SG - Singapore 945
CN - Cina 519
BR - Brasile 339
IT - Italia 313
VN - Vietnam 286
HK - Hong Kong 192
DE - Germania 187
UA - Ucraina 146
GB - Regno Unito 107
BD - Bangladesh 101
TR - Turchia 81
FI - Finlandia 78
FR - Francia 74
JP - Giappone 66
CA - Canada 62
IN - India 56
SE - Svezia 47
RU - Federazione Russa 45
MX - Messico 40
AR - Argentina 32
NL - Olanda 29
ID - Indonesia 25
ZA - Sudafrica 25
PL - Polonia 23
ES - Italia 21
IQ - Iraq 21
CO - Colombia 18
LT - Lituania 15
MY - Malesia 11
PK - Pakistan 11
UZ - Uzbekistan 11
KE - Kenya 10
MA - Marocco 10
AT - Austria 9
BE - Belgio 9
EG - Egitto 9
PH - Filippine 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
DK - Danimarca 7
SA - Arabia Saudita 7
BO - Bolivia 6
EC - Ecuador 6
TN - Tunisia 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
IE - Irlanda 5
JM - Giamaica 5
AL - Albania 4
CL - Cile 4
ET - Etiopia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
PY - Paraguay 4
BY - Bielorussia 3
CH - Svizzera 3
DZ - Algeria 3
PE - Perù 3
SV - El Salvador 3
BB - Barbados 2
BW - Botswana 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MW - Malawi 1
NG - Nigeria 1
NO - Norvegia 1
Totale 7.794
Salva come PNG Salva come JPEG
Città #
Singapore 591
Ashburn 532
San Jose 295
Woodbridge 210
Santa Clara 205
Hong Kong 187
Chandler 174
Fairfield 167
Jacksonville 152
Beijing 142
Houston 131
New York 108
Ho Chi Minh City 93
Ann Arbor 88
Los Angeles 77
Hanoi 76
Wilmington 76
Munich 75
Council Bluffs 71
Seattle 71
Dallas 64
Tokyo 64
Nanjing 52
Milan 48
Cambridge 46
Princeton 44
Izmir 43
Lauterbourg 42
São Paulo 39
Shanghai 33
Helsinki 32
Boardman 28
Mexico City 28
San Diego 27
Bologna 26
Orem 25
Toronto 25
Buffalo 24
Ferrara 24
Chicago 22
Denver 22
London 22
Warsaw 20
Atlanta 19
Bremen 19
Brooklyn 19
Phoenix 19
Rome 18
Stockholm 17
Da Nang 16
The Dalles 16
Turku 16
Naples 15
Jakarta 14
Johannesburg 14
Shenyang 14
Chennai 13
Hefei 13
Montreal 13
Falls Church 11
San Francisco 11
Tashkent 11
Tianjin 11
Boston 9
Düsseldorf 9
Haiphong 9
Nairobi 9
New Delhi 9
Poplar 9
Rio de Janeiro 9
Brussels 8
Changsha 8
Columbus 8
Dhaka 8
Jiaxing 8
Moscow 8
Nanchang 8
Amsterdam 7
Belo Horizonte 7
Dearborn 7
Hebei 7
Kuala Lumpur 7
Manchester 7
Miami 7
Nuremberg 7
Sydney 7
Thái Nguyên 7
Acireale 6
Baghdad 6
Bogotá 6
Cairo 6
Falkenstein 6
Florence 6
Goiânia 6
Kunming 6
Newark 6
Ninh Bình 6
Odense 6
Redwood City 6
Tampa 6
Totale 4.887
Salva come PNG Salva come JPEG
Nome #
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 267
Reperfusion Damage - A Story of Success, Failure, and Hope 254
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 216
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 210
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 210
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 208
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial 202
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 200
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 194
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 185
Heart Rate Variability Relates with Competition Performance in Professional Soccer Players 185
Bradykinin and coronary artery disease 179
A modern fairy tale 178
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 178
The heart rate story 177
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study 177
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 176
Multimodality imaging in acromegalic cardiomiopathy: a case report 174
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 169
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 168
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 168
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 168
Oxidative stress during myocardial ischaemia and heart failure 165
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 164
Screening della fibrillazione atriale nella popolazione generale: esperienza della campagna educazionale sul rischio cardiovascolare della Regione Emilia-Romagna [Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region] 163
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 163
Angiotensin II overproduction: enemy of the vessel wall 163
CORRENTE IF COME NUOVO TARGET TERAPEUTICO NELL’ANGINA STABILE 159
CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS 153
Tirofiban: A critical reappraisal of the clinical use, recent developments and future perspectives 152
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 151
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score 149
Safety and efficacy of new-generation coronary bioresorbable scaffolds 149
Interventricular dyssynchrony does not identify CRT responders in patients with heart failure 147
Ferrara VI 147
Role of duration of post-stress left ventricular dysfunction in the identification of multivassel coronary artery disease: a Tc-99m sestamibi gated-SPECT study 142
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 132
FERRARA: CITTÀ DELLA PREVENZIONE 130
LEFT VENTRICULAR REMODELLING AT THE LIMITS 120
Ferrara II 114
Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial. 112
ZERO FLUOROSCOPY CARDIAC ABLATION: A NOVEL WORKFLOW FOR ATRIAL FIBRILLATION 107
P299 WATCHMAN DEVICE THROMBOSIS FOLLOWING THE PERCUTANEOUS CLOSURE OF THE LEFT ATRIUM APPENDAGE: A "CUL–DE–SAC" IN THE ANTITHROMBOTIC STRATEGY 103
P1 ATRIAL TACHYCARDIA IN PATIENT WITH TRANSFUSION–DEPENDENT BETA THALASSEMIA AND SEVERE HEMOCHROMATOSIS: A CASE REPORT 100
P422 CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE 99
One-year outcome of elderly patients with endocarditis: a retrospective observational study 96
P18 ATRIAL FIBRILLATION IN BETA–THALASSAEMIA: PHYSIOPATHOLOGY AND CLINICAL MANAGEMENT 90
The future of cardiovascular prevention: between fiction and reality 78
Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy 73
null 61
Cardiovascular prevention: sometimes dreams can come true 53
Physical activity and cardiac rehabilitation after myocardial infarction: the risk of obtaining large benefits 13
Totale 7.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 561
Totale 37.794
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022350 0 43 24 13 18 18 15 21 14 25 35 124
2022/2023423 40 10 16 44 84 67 20 41 54 6 34 7
2023/2024282 19 37 10 4 13 47 21 23 5 8 14 81
2024/20251.326 23 35 87 71 162 127 44 53 270 126 177 151
2025/20263.834 397 155 276 475 576 259 386 236 336 400 226 112
2026/2027254 125 129 0 0 0 0 0 0 0 0 0 0
Totale 7.891